Search alternatives:
significant sharp » significant short (Expand Search), significant shape (Expand Search), significant gap (Expand Search)
sharp increase » year increase (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
significant sharp » significant short (Expand Search), significant shape (Expand Search), significant gap (Expand Search)
sharp increase » year increase (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
-
1
-
2
Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period.
Published 2025“…Ginkgo biloba showed a significant decline from 2008 to 2018, followed by a sharp increase from 2018 onward. …”
-
3
-
4
Join-point regression analysis of the statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period.
Published 2025“…<p>A significant decline for fluphenazine was observed from 2014 to 2017, followed by a sharp increase starting from 2017.…”
-
5
-
6
-
7
-
8
Mean and standard error of the mean for force capability according to anchor point level change.
Published 2022Subjects: -
9
-
10
-
11
-
12
Spatial information is significantly decreased in dCA1 and vCA1 in APP/PS1 mice.
Published 2024“…(B) In dCA1, spatial information was decreased in APP/PS1 mice relative to C57BL/6 controls (mean ± std: C57BL/6 = 0.132 ± 0.048, APP/PS1 = 0.128 ± 0.051, p < 0.005, two-sided Wilcoxon rank-sum test, n<sub>C57BL/6</sub> = 305 units from 5 recording sessions, n<sub>APP/PS1</sub> = 180 units from 4 recording sessions). …”
-
13
-
14
-
15
-
16
-
17
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
18
-
19
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
20